| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |